Protocol for Radiofrequency Ablation of Pulmonary Neoplasms

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00232128

Enrollment

Unknown

Registered

2005-10-04

Start date

2003-06-30

Completion date

Unknown

Last updated

2007-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Neoplasms

Brief summary

This research trial involves the development of a new treatment for lung tumors. It is for patients whose tumor cannot be surgically removed, have refused surgery, or the tumor has not responded well to other forms of treatment. This treatment uses a needle probe to deliver energy into the lung tumor. This probe is placed utilizing a CT scan image. The energy heats the tumor causing tumor cell death.

Interventions

PROCEDURERadiofrequency Ablation of pulmonary neoplasms

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

The patients enrolled in this study should be judged to have sufficient survival to benefit from control of local disease and include at least one of the following: 1. unresectable primary or metastatic lung tumors 2. may benefit from multiple modalities of therapy 3. chemotherapeutic or radiation oncologic options have been exhausted

Exclusion criteria

1\. co-existing morbidities that preclude the use of surgery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026